🇮🇳 India Warehouse EVEROLIMUS — 0.5mg per tablet, 100-count pack. mTOR inhibitor for advanced renal cell carcinoma, neuroendocrine tumors, breast cancer (with exemestane), tuberous sclerosis complex, and organ transplant rejection.
Key warning: Pneumonitis — monitor respiratory symptoms (can be asymptomatic early). Stomatitis management with specific rinses (not chlorhexidine). Hold before surgery. Avoid live vaccines. CYP3A4/P-gp substrate.
🇮🇳 India Warehouse LEFLUNOMIDE — 20mg per tablet, 100-count pack. DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite.
Key warning: TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate.
🇮🇳 India Warehouse LEFLUNOMIDE — 10mg per tablet, 100-count pack. DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite.
Key warning: TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate.
🇮🇳 India Warehouse LEFLUNOMIDE — 20mg per tablet, 100-count pack. DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite.
Key warning: TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate.
🇮🇳 India Warehouse LEFLUNOMIDE — 10mg per tablet, 100-count pack. DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite.
Key warning: TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate.
🇮🇳 India Warehouse LEFLUNOMIDE — 20mg per tablet, 100-count pack. DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite.
Key warning: TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate.
🇮🇳 India Warehouse LENALIDOMIDE — 10mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENALIDOMIDE — 25mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENALIDOMIDE — 5mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENALIDOMIDE — 25mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENALIDOMIDE — 10mg per tablet, 100-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENVATINIB — 4mg per tablet, 100-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.
🇮🇳 India Warehouse LENVATINIB — 10mg per tablet, 100-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.
🇮🇳 India Warehouse LENVATINIB — 10mg per tablet, 120-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.
🇮🇳 India Warehouse LENVATINIB — 4mg per tablet, 120-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.
🇮🇳 India Warehouse LENVATINIB — 4mg per tablet, 100-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.